3 of JPMorgan’s Top Stocks for February – Week of 2/4

With a reputation built on expertise and a keen understanding of market dynamics, JPMorgan Chase & Co. emerges as a trusted source for investment insights. Today, we delve into JPMorgan’s top picks for February, highlighting three stocks that have captured the attention of the financial giant. These selections are poised to potentially deliver strong returns in the coming month, making them essential additions to any investor’s watchlist.

Here are three of JPMorgan’s top stocks for the month –

Insulet Corporation – SYM: PODD
Recent Price: $201.31
Price Target: $233.13
Firms with Buy Rating: Piper Sandler, Morgan Stanley, Wells Fargo
Description: Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager.

Your Money or Your Privacy?

spad 3

The digital dollar might change more than just currency. Its implications for privacy, autonomy, and personal finance are terrifying. If you don’t take control of your money and your privacy, you could lose both to a digital dollar.

Protect Your Financial Future Now!

Prologis, Inc. – SYM: PLD
Recent Price: $130.41
Price Target: $143.69
Firms with Buy Rating: Jefferies, Morgan Stanley, Goldman Sachs
Description: Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At December 31, 2023, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 6,700 customers principally across two major categories: business-to-business and retail/online fulfillment.

The #1 Energy Passive Income Investment for 2024

It’s not a stock, bond or private company…

But this little-known alternative investment could hand you BIG MONTHLY INCOME from the oil and gas surge in 2024.



Entergy Corporation – SYM: ETR
Recent Price: $98.86
Price Target: $109.40
Firms with Buy Rating: Guggenheim, Wells Fargo, Mizuho Securities
Description: Entergy Corporation, together with its subsidiaries, engages in the production and retail distribution of electricity in the United States. The company operates in two segments, Utility and Entergy Wholesale Commodities. The Utility segment generates, transmits, distributes, and sells electric power in portions of Arkansas, Louisiana, Mississippi, and Texas, including the City of New Orleans; and distributes natural gas. The Entergy Wholesale Commodities segment engages in the ownership, operation, and decommissioning of nuclear power plants; and ownership of interests in non-nuclear power plants that sell electric power to wholesale customers, as well as provides services to other nuclear power plant owners. It generates electricity through gas, nuclear, coal, hydro, and solar power sources. The company sells energy to retail power providers, utilities, electric power co-operatives, power trading organizations, and other power generation companies. The company’s power plants have approximately 24,000 megawatts (MW) of electric generating capacity, which include 5,000 MW of nuclear power. It delivers electricity to 3 million utility customers in Arkansas, Louisiana, Mississippi, and Texas. Entergy Corporation was founded in 1913 and is headquartered in New Orleans, Louisiana.

deal of the month

best growth stocks


Bundle package – lifetime subscriptions for all products


Recent posts


Connect with Us

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.